Abstract Allergic contact dermatitis (ACD) is a type IV hypersensitivity mainly mediated by Th1/Th17 immune response. Topical corticosteroid is currently the first-line treatment for allergic contact dermatitis (ACD) and systemic administration of immunosuppressive drugs are used in patients with severe disseminated cases. However. increased risk of adverse effects has limited their use. https://www.jmannino.com/limited-find-Florida-State-University-FSU-Gold-Big-Bang-Lite-Headband-hot-grab/